AS ONE Corporation
Notice of December 2025 Standalone Monthly Performance (Preliminary Report)
Sales for December 2025 grew year-over-year in all three major sectors, resulting in an overall +9.0% increase year-over-year. The expansion of the EC channel contributed significantly.
Key Figures
- December Sales Year-over-Year: +9.0%
- Laboratory Sales Year-over-Year: +12.1%
- Industry Sales Year-over-Year: +4.9%
AI要約
Overview of Monthly Sales
According to the standalone preliminary monthly performance for December 2025, sales in the three major sectors (Laboratory, Industry, Medical) all showed positive year-over-year growth. Especially the Laboratory sector performed strongly with a +12.1% increase year-over-year, driven by overall expansion of the EC channel. Industry sales grew by +4.9%, and Medical sales, supported by strong demand for low-price consumables and other products, rose by +4.0%, marking two consecutive months of positive growth. Daily sales figures adjusted for changes in business days also increased year-over-year.
Future Publication Schedule and Notes
This material provides partial preliminary standalone figures and does not include adjustments for intercompany transactions within the consolidated group or deduction items at the time of settlement. For reference, fiscal 2024 standalone sales amounted to 99,397 million yen, and consolidated sales totaled 103,751 million yen. Results for June, September, December, and March will be disclosed with the earnings reports. Investors should consider this as preliminary data and closely monitor official financial results announcements.
